Strategic Consulting
We guide critical development decisions with senior‑level attention, ensuring experiments are purposeful and defensible.
Problem
Formulations are often selected too early or without clear justification, leading to rework and delays.
Solution
Create defensible, stage‑appropriate formulations that align with molecule risk, CMC strategy, and product profile.
Problem
CRO/CMO execution can drift toward non‑value‑added experiments and unclear ownership.
Solution
Select and manage CROs/CMOs with clear decision gates, eliminating unnecessary experiments and accelerating outcomes.
Problem
Risk trade‑offs are often communicated without context or alignment to expectations.
Solution
Provide risk‑based recommendations aligned with FDA/EMA expectations, supported by transparent rationale.